MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”), announced that Stefan Weber, the company’s Chief Executive Officer, will present a clinical, commercial and corporate update at the 23rd Annual BioCentury Future Leaders in the Biotech Industry Conference at 11:00 a.m. ET on March 11, 2016. The conference is being held at the Millennium Broadway Hotel & Conference Center in New York City, NY. Newron is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain.
